At 36 weeks, a reduction in fibrosis without worsening of MASH occurred in 8 of 61 patients (13%) in the placebo group, in 10 of 57 patients (18%) in the 28-mg efruxifermin group (difference from ...

SAN DIEGO — Boston Pharmaceuticals’ once-monthly efimosfermin alfa (formerly BOS-580) prescribed for metabolic dysfunction–associated steatohepatitis (MASH) with F2 and F3 fibrosis ...

As of the end of March, more than 17,000 MASH patients were actively taking Rezdiffra, compared with more than 11,800 at year-end 2024, according to Madrigal. Rezdiffra’s speed of adding new ...

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated steatohepatitis (MASH). Researchers have developed an innovative ...

Some have been standing there for over an hour. The band that’s worth the wait? Brass Mash. Aptly named, Brass Mash is a local SLO County brass-instrument-based mash-up band. “It’s not a ...

Zony Mash Beer Project (3940 Thalia St.) has announced it is closing, with its final day scheduled for June 1. The brewery and its taproom remain open until then, serving Wednesday through Sunday ...

After 24 years, Mash House Brewing Company in Fayetteville has closed. The brewery and restaurant, known for its handcrafted beers and meals, announced its closure on April 10. Mash House's ...

Here’s what to know about the road ahead. I had never heard of [MASH]. I didn’t realize that fatty liver could turn into MASH, and I didn’t realize that it was a terminal illness.

MASH and MASLD are prevalent, complex diseases often accompanied by metabolic comorbidities like obesity and diabetes. GLP-1 receptor agonists, such as semaglutide, show promise in resolving NASH ...

Nwd1 gene deletion triggers MASH-like pathology in mice Study highlights the role of the Nwd1 gene in liver disease, paving the way for new therapies and better liver health Date: March 11, 2025 ...

Resmetirom significantly reduced liver stiffness in patients with compensated MASH cirrhosis, with a 6.7 kPa decrease over 2 years. The reduction in liver stiffness may lower the risk of liver ...

Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...